LPTX - リ―プ・セラピュ―ティクス (LEAP THERAPEUTICS INC.)

LPTXのニュース

   Leap Therapeutics Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants  2020/06/22 20:05:00 PR Newswire
CAMBRIDGE, Mass., June 22, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the closing of a public offering of 20,250,000 shares of common stock and pre-funded warrants to…
   Leap Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants  2020/06/17 20:01:00 PR Newswire
CAMBRIDGE, Mass., June 17, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that it has commenced an underwritten public offering of its common stock and, in lieu of common…
   Leap Therapeutics Reports First Quarter 2020 Financial Results  2020/05/14 11:00:00 PR Newswire
CAMBRIDGE, Mass., May 14, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the first quarter ended March 31, 2020. Leap First Quarter Highlights:…
   Leap Therapeutics to Present Updated Data for DKN-01 Monotherapy and Paclitaxel Combination In Gynecologic Cancers  2020/04/23 11:00:00 PR Newswire
CAMBRIDGE, Mass., April 23, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced updated clinical data from its ongoing Phase 2 clinical trial of DKN-01, its anti-Dickkopf-1…
   Leap Therapeutics to Present at Cowen 40th Annual Health Care Conference  2020/02/26 12:00:00 PR Newswire
CAMBRIDGE, Mass., Feb. 26, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli, Ph.D., Chairman, President and Chief Executive Officer, Douglas E….
   Leap Therapeutics to Present at Cowen 40th Annual Health Care Conference  2020/02/26 12:00:00 PR Newswire
CAMBRIDGE, Mass., Feb. 26, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli, Ph.D., Chairman, President and Chief Executive Officer, Douglas E….
   The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study  2020/02/20 12:06:25 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 19) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Akebia Therapeutics Inc (NASDAQ: AKBA ) Anavex Life Sciences Corp (NASDAQ: AVXL ) Arcus Biosciences Inc (NYSE: RCUS ) Ascendis Pharma A/S (NASDAQ: ASND ) AVITA MED LTD/S ADR (NASDAQ: RCEL )(reacted to its half-yearly results) Bio-Rad Laboratories, Inc. Class A (NYSE: BIO ) Calithera Biosciences Inc (NASDAQ: CALA ) ChemoCentryx Inc (NASDAQ: CCXI ) Cue Biopharma Inc (NASDAQ: CUE )(said its therapeutic Immuno-STAT platform will be featured in a Merck & Co., Inc.'s (NYSE: MRK ) presentation at the Antigen Specific Immune Tolerance Drug Development Summit) DexCom, Inc. (NASDAQ: DXCM ) Fate Therapeutics Inc (NASDAQ: FATE ) Fulgent Genetics Inc (NASDAQ: FLGT ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) GENMAB A/S/S ADR (NASDAQ: GMAB )(reacted to its quarterly and full-year results) Grifols SA - ADR ADR Class B (NASDAQ: GRFS ) Insulet Corporation (NASDAQ: PODD ) Intuitive Surgical, Inc.
   Leap Therapeutics to Present at 22nd Annual BIO CEO & Investor Conference  2020/02/04 12:00:00 PR Newswire
CAMBRIDGE, Mass., Feb. 4, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E. Onsi, Chief Financial Officer, will present a corporate overview at the 22nd…
   NNVC, SLM, FCEL and TTPH among midday movers  2020/01/23 17:39:48 Seeking Alpha
Gainers: Trans World Entertainment TWMC +260%. Co-Diagnostics CODX +89%. NanoViricides NNVC +55%. Kaleido BioSciences (NASDAQ:KLDO) +37%. Leap Therapeutics
   Leap's DKN-01 shows positive effect in esophagogastric cancer  2020/01/23 12:48:50 Seeking Alpha
Updated results from a recently completed Phase 1/2 clinical trial, P102 (KEYNOTE-731), evaluating Leap Therapeutics' (NASDAQ:LPTX) DKN-01, combined with p
   Leap Therapeutics to Present at Cowen 40th Annual Health Care Conference  2020/02/26 12:00:00 PR Newswire
CAMBRIDGE, Mass., Feb. 26, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli, Ph.D., Chairman, President and Chief Executive Officer, Douglas E….
   The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study  2020/02/20 12:06:25 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 19) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Akebia Therapeutics Inc (NASDAQ: AKBA ) Anavex Life Sciences Corp (NASDAQ: AVXL ) Arcus Biosciences Inc (NYSE: RCUS ) Ascendis Pharma A/S (NASDAQ: ASND ) AVITA MED LTD/S ADR (NASDAQ: RCEL )(reacted to its half-yearly results) Bio-Rad Laboratories, Inc. Class A (NYSE: BIO ) Calithera Biosciences Inc (NASDAQ: CALA ) ChemoCentryx Inc (NASDAQ: CCXI ) Cue Biopharma Inc (NASDAQ: CUE )(said its therapeutic Immuno-STAT platform will be featured in a Merck & Co., Inc.'s (NYSE: MRK ) presentation at the Antigen Specific Immune Tolerance Drug Development Summit) DexCom, Inc. (NASDAQ: DXCM ) Fate Therapeutics Inc (NASDAQ: FATE ) Fulgent Genetics Inc (NASDAQ: FLGT ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) GENMAB A/S/S ADR (NASDAQ: GMAB )(reacted to its quarterly and full-year results) Grifols SA - ADR ADR Class B (NASDAQ: GRFS ) Insulet Corporation (NASDAQ: PODD ) Intuitive Surgical, Inc.
   Leap Therapeutics to Present at 22nd Annual BIO CEO & Investor Conference  2020/02/04 12:00:00 PR Newswire
CAMBRIDGE, Mass., Feb. 4, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E. Onsi, Chief Financial Officer, will present a corporate overview at the 22nd…
   NNVC, SLM, FCEL and TTPH among midday movers  2020/01/23 17:39:48 Seeking Alpha
Gainers: Trans World Entertainment TWMC +260%. Co-Diagnostics CODX +89%. NanoViricides NNVC +55%. Kaleido BioSciences (NASDAQ:KLDO) +37%. Leap Therapeutics
   Leap's DKN-01 shows positive effect in esophagogastric cancer  2020/01/23 12:48:50 Seeking Alpha
Updated results from a recently completed Phase 1/2 clinical trial, P102 (KEYNOTE-731), evaluating Leap Therapeutics' (NASDAQ:LPTX) DKN-01, combined with p

calendar